Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 18;3(4):1455-1458.
doi: 10.1002/jha2.599. eCollection 2022 Nov.

Cardiovascular screening prior to stem cell transplantation in the United Kingdom

Affiliations

Cardiovascular screening prior to stem cell transplantation in the United Kingdom

David G Gent et al. EJHaem. .
No abstract available

Keywords: cardiovascular screening; hematopoietic cell transplantation; stem cell transplantation.

PubMed Disclaimer

Conflict of interest statement

Professor Wright has received consultancy and speaker fees from Boston Scientific and Medtronic outside the submitted work. All other authors have no relationships relevant to the content of this paper to disclose.

Figures

FIGURE 1
FIGURE 1
The spread of LVEF values used as a boundary for transplant exclusion. The figure shows the different LVEF values used as a cut‐off and the number of centres using each value. Only one centre specified that, although they used ≤40% as a boundary, if the LVEF was ≤50% a reduced intensity conditioning regimen was used

References

    1. Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, et al. Long‐term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol. 2011;29:2230. - PMC - PubMed
    1. Armenian SH, Chow EJ. Cardiovascular disease in survivors of hematopoietic cell transplantation. Cancer. 2014;120:469–79. - PMC - PubMed
    1. Bhatia S, Dai C, Landier W, Hageman L, Wu J, Schlichting E, et al. Trends in late mortality and life expectancy after autologous blood or marrow transplantation over three decades: a BMTSS report. J Clin Oncol. 2022;40:1991–2003. - PMC - PubMed
    1. Bhatia S, Dai C, Landier W, Hageman L, Wu J, Schlichting E, et al. Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report. JAMA Oncol. 2021;7:1626–34. - PMC - PubMed
    1. Lenihan DJ, Fradley MG, Dent S, Brezden‐Masley C, Carver J, Filho RK, et al. Proceedings from the global cardio‐oncology summit: the top 10 priorities to actualize for cardiooncology. JACC CardioOncol. 2019;1:256–72. - PMC - PubMed

LinkOut - more resources